{"id": "1355198626688065545", "creation": 1611939505.0, "user_id": "1247376635004936192", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "Johnson &amp; Johnson Announces Single-Shot Janssen #COVID19 #Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial\n\nVaccine 72% Effective in the US and 66% Effective Overall at Preventing Moderate to Severe COVID-19.\nhttps://t.co/AW2sXDwDoQ", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}